Advanced search
Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 50, 2020 - Issue 5
Submit an article Journal homepage
230
Views
4
CrossRef citations to date
0
Altmetric
Animal Pharmacokinetics and Metabolism

Effects of antibiotics on the pharmacokinetics of indoxyl sulfate, a nephro-cardiovascular toxin

Shu-Shang LuoSchool of Pharmacy, China Medical University, Taichung, Taiwan, ROC; View further author information
,
Chung-Ping YuDepartment of Pharmacy, China Medical University Hospital, Taichung, Taiwan, ROC; ORCID Iconhttp://orcid.org/0000-0002-1742-2344View further author information
ORCID Icon,
Yow-Wen HsiehSchool of Pharmacy, China Medical University, Taichung, Taiwan, ROC; ;Department of Pharmacy, China Medical University Hospital, Taichung, Taiwan, ROC; View further author information
,
Pei-Dawn Lee ChaoSchool of Pharmacy, China Medical University, Taichung, Taiwan, ROC; View further author information
,
Douglas H. SweetDepartment of Pharmaceutics, Virginia Commonwealth University, Richmond, USAView further author information
,
Yu-Chi HouSchool of Pharmacy, China Medical University, Taichung, Taiwan, ROC; ;Department of Pharmacy, China Medical University Hospital, Taichung, Taiwan, ROC; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-3995-7219View further author information
ORCID Icon &
Shiuan-Pey LinSchool of Pharmacy, China Medical University, Taichung, Taiwan, ROC; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-6186-2101View further author information
ORCID Icon show all
Pages 588-592 | Received 26 Jul 2019, Accepted 22 Aug 2019, Published online: 04 Sep 2019

References

  • Bird ST, Etminan M, Brophy JM, et al. (2013). Risk of acute kidney injury associated with the use of fluoroquinolones. CMAJ 185:E475–82.
  • Deguchi T, Ohtsuki S, Otagiri M, et al. (2002). Major role of organic anion transporter 3 in the transport of indoxyl sulfate in the kidney. Kidney Int 61:1760–8.
  • Deguchi T, Kusuhara H, Takadate A, et al. (2004). Characterization of uremic toxin transport by organic anion transporters in the kidney. Kidney Int 65:162–74.
  • Deguchi T, Kouno Y, Terasaki T, et al. (2005). Differential contributions of rOat1 (Slc22a6) and rOat3 (Slc22a8) to the in vivo renal uptake of uremic toxins in rats. Pharm Res 22:619–27.
  • Fanos V, Cataldi L. (2001). Renal transport of antibiotics and nephrotoxicity: a review. J Chemother 13:461–72.
  • Fritz G, Barner C, Schindler R, et al. (2003). Amoxicillin-induced acute renal failure. Nephrol Dial Transplant 18:1660–2.
  • Fujita T, Ishihara K, Yasuda S, et al. (2012). In vivo kinetics of indoxyl sulfate in humans and its renal interaction with angiotensin-converting enzyme inhibitor quinapril in rats. J Pharmacol Exp Ther 341:626–33.
  • Ito S, Yoshida M. (2014). Protein-bound uremic toxins: new culprits of cardiovascular events in chronic kidney disease patients. Toxins 6:665–78.
  • Jariyawat S, Sekine T, Takeda M, et al. (1999). The interaction and transport of beta-lactam antibiotics with the cloned rat renal organic anion transporter 1. J Pharmacol Exp Ther 290:672–7.
  • Jung KY, Takeda M, Shimoda M, et al. (2002). Involvement of rat organic anion transporter 3 (rOAT3) in cephaloridine-induced nephrotoxicity: in comparison with rOAT1. Life Sci 70:1861–74.
  • Khamdang S, Takeda M, Babu E, et al. (2003). Interaction of human and rat organic anion transporter 2 with various cephalosporin antibiotics. Eur J Pharmacol 465:1–7.
  • Lin CJ, Liu HL, Pan CF, et al. (2012). Indoxyl sulfate predicts cardiovascular disease and renal function deterioration in advanced chronic kidney disease. Arch Med Res 43:451–6.
  • Mac K, Chavada R, Paull S, et al. (2015). Cefepime induced acute interstitial nephritis-a case report. BMC Nephrol 16:15.
  • Meijers BK, De Loor H, Bammens B, et al. (2009). p-Cresyl sulfate and indoxyl sulfate in hemodialysis patients. Clin J Am Soc Nephrol 4:1932–8.
  • Meropol SB, Chan KA, Chen Z, et al. (2008). Adverse events associated with prolonged antibiotic use. Pharmacoepidemiol Drug Saf 17:523–32.
  • Nair AB, Jacob S. (2016). A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm 7:27–31.
  • Naughton CA. (2008). Drug-induced nephrotoxicity. Am Fam Physician 78:743–50.
  • Niwa T. (1996). Organic acids and the uremic syndrome: protein metabolite hypothesis in the progression of chronic renal failure. Semin Nephrol 16:167–82.
  • Stratta P, Lazzarich E, Canavese C, et al. (2007). Ciprofloxacin crystal nephropathy. Am J Kidney Dis 50:330–5.
  • Taber SS, Mueller BA. (2006). Drug-associated renal dysfunction. Crit Care Clin 22:357–74.
  • Takeda M, Babu E, Narikawa S, Endou H. (2002). Interaction of human organic anion transporters with various cephalosporin antibiotics. Eur J Pharmacol 438:137–42.
  • Ueo H, Motohashi H, Katsura T, Inui K. (2005). Human organic anion transporter hOAT3 is a potent transporter of cephalosporin antibiotics, in comparison with hOAT1. Biochem Pharmacol 70:1104–13.
  • Vanholder R, Pletinck A, Schepers E, Glorieux G. (2018). Biochemical and clinical impact of organic uremic retention solutes: a comprehensive update. Toxins 10:33.
  • Vanwert AL, Srimaroeng C, Sweet DH. (2008). Organic anion transporter 3 (oat3/slc22a8) interacts with carboxyfluoroquinolones, and deletion increases systemic exposure to ciprofloxacin. Mol Pharmacol 74:122–31.
  • Wolman AT, Gionfriddo MR, Heindel GA, et al. (2013). Organic anion transporter 3 interacts selectively with lipophilic β-lactam antibiotics. Drug Metab Dispos 41:791–800.
  • Wu W, Bush KT, Nigam SK. (2017). Key role for the organic anion transporters, OAT1 and OAT3, in the in vivo handling of uremic toxins and solutes. Sci Rep 7:4939.
  • Yu CP, Sweet DH, Peng YH, et al. (2017). Effects of nonsteroidal anti-inflammatory drugs on the renal excretion of indoxyl sulfate, a nephro-cardiovascular toxin, in rats. Eur J Pharm Sci 101:66–70.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.